Study of asthma inflammation and diet effects
Part of Immune system & allergy, Lungs & breathing clinical trials.
This early-phase study looks at how asthma-related inflammation works and whether a diet-related approach could help. It may be most relevant if you have confirmed asthma and can follow the study’s diet requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have asthma diagnosed by a specialist or test results that support asthma (like response to methacholine or breathing medicine).
- Your lung function test (FEV1) is within the study’s acceptable range.
- You can give informed consent to join the study.
- You do not have diabetes with fasting blood sugar above 110 mg/dL.
- You do not have milk or coconut allergies, and you can stick to the study diet plan.
- You are not a current smoker, and you have not smoked more than 10 pack-years in the past.
- You do not have major other health problems that could interfere (for example, serious heart or kidney disease that is not controlled).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a vegan diet (no animal foods) affects inflammation in young adults with and without asthma. It may help show if what you eat can improve asthma control.
This study tests whether a specially designed diet plan can help adults whose asthma is not well controlled. You will use a smartphone app to track your food and symptoms, and the study will provide dietary guidance.
This study follows people with moderate-to-severe asthma and repeatedly checks how their lungs and symptoms relate to environmental exposures over time. It may help researchers better understand what triggers asthma and how exposures affect asthma control.
This study screens adults to better understand and manage asthma and allergic diseases. It may help identify treatments or management strategies that improve quality of life.
This Phase 2 study tests anti-inflammatory lipid mediators in people with asthma. You may be eligible if your asthma is not well controlled despite regular inhaler use and you meet the specific lung function and health criteria.
This study tests a program that combines exercise and other support to help people with difficult-to-control asthma feel better and be more active. It aims to improve your symptoms and quality of life.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.